Kidney injury molecule-1 and N-acetyl-ß-d-glucosaminidase in chronic heart failure: Possible biomarkers of cardiorenal syndrome

European Journal of Heart Failure

Volumn 13, Issue 10, 2011, Pages 1104-1110

  Jungbauer, Carsten G ^a   Birner, Christoph ^a   Jung, Bettina ^a   Buchner, Stefan ^a   Lubnow, Matthias ^a   Von Bary, Christian ^a   Endemann, Dierk ^a   Banas, Bernhard ^a   MacK, Matthias ^a   Böger, Carsten A ^a   Riegger, Günter ^a   Luchner, Andreas ^a  

^a Klinik und Poliklinik fuer Innere Medizin II   (Germany)

Author keywords

Cardiorenal syndrome; Chronic heart failure; KIM 1; NAG; Renal biomarkers

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KIDNEY INJURY MOLECULE 1; LOOP DIURETIC AGENT; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CARDIORENAL SYNDROME; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HOSPITAL READMISSION; HUMAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; URINE LEVEL;

ACETYLGLUCOSAMINIDASE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIO-RENAL SYNDROME; CHRONIC DISEASE; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; HEART FAILURE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RECEPTORS, VIRUS; SEVERITY OF ILLNESS INDEX; SYNDROME; URINALYSIS;

EID: 80053271214     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfr102     Document Type: Article

References (25)

1. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House AA, Katz N, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 2010;31:703-711.
2. Pokhrel N, Dhakal B, Arora RR. Cardiorenal syndrome: A literature review. Exp Clin Cardiol 2008;13:165-170.
3. Hata N, Yokoyama S, Shinada T, Kobayashi N, Shirakabe A, Tomita K, Kitamura M, Kurihara O, Takahashi Y. Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure population. Eur J Heart Fail 2010;12:32-37.
4. Vaz Pérez A, Otawa K, Zimmermann AV, Stockburger M, Müller-Werdan U, Werdan K, Schmidt HB, Ince H, Rauchhaus M. The impact of impaired renal function on mortality in patients with acutely decompensated chronic heart failure. Eur J Heart Fail 2010;12:122-128.
5. Damman K, Jaarsma T, Voors AA, Navis G, Hillege HL, van Veldhuisen DJ, COACH investigators. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail 2009;11:847-854.
6. Scrutinio D, Passantino A, Santoro D, Catanzaro R. The cardiorenal anaemia syndrome in systolic heart failure: prevalence, clinical correlates, and long-term survival. Eur J Heart Fail 2011;13:61-67.
7. Shlipak MG, Massie BM. The clinical challenge of cardiorenal syndrome. Circulation 2004;110:1514-1517.
8. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: Guyton revisited. Eur Heart J 2005;26:11-17.
9. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M. Kidney Injury Molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998;273:4135-4142.
10. Tassi C, Abbritti G, Mancuso F, Morucci P, Feligioni L, Muzi G. Activity and isoenzyme profile of N-acetyl-beta-D-glucosaminidase in urine from workers exposed to cadmium. Clin Chim Acta 2000;299:5-64.
11. Price RG. The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 1992; 38(Suppl 1):14-19.
12. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231-1238.
13. Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens 2008;17:127-132.
14. Damman K, Van Veldhuisen DJ, Navis G, Vaidya VS, Smilde TD, Westenbrink BD, Bonventre JV, Voors AA, Hillege HL. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 2010;96:1297-1302.
15. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
16. Schrier RW,Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004;114:5-14.
17. Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: systematic review. Kidney Int 2008;73: 1008-1016.
18. Struthers AD, MacDonald TM. Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc Res 2004;61:663-670.
19. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009;53:582-588.
20. Ronco C, Maisel A. Volume overload and cardiorenal syndromes. Congest Heart Fail 2010;16(Suppl 1):Si-Siv; quiz Svi.
21. Bock JS, Gottlieb SS. Cardiorenal syndrome: new perspectives. Circulation 2010; 121:2592-2600.
22. Poniatowski B, Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease. Kidney Blood Press Res 2009;32:77-80.
23. Damman K, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail 2008;10:997-1000.
24. Bolignano D, Basile G, Parisi P, Coppolino G, Nicocia G, Buemi M. Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure. Rejuvenation Res 2009;12:7-14.
25. Shaker O, El-Shehaby A, El-Khatib M. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography. Angiology 2010;61: 731-736.